Background {#Sec1}
==========

Fatty liver is associated with dyslipidemia, type 2 diabetes mellitus, and obesity. The SMXA-5 mouse is an animal model of high fat diet (HFD)-induced type 2 diabetes and fatty liver \[[@CR1]\]. The SMXA-5 strain is an SMXA-recombinant inbred (RI) strain established from breeding between SM/J mice and A/J mice \[[@CR2]\], and thus the SMXA-5 genome is a mosaic genome derived from SM/J mice and A/J mice. On a commercial chow diet, SM/J mice and A/J mice did not show hyperglycemia and impaired glucose tolerance (IGT), but SMXA-5 mice showed IGT \[[@CR3]\]. On a high-carbohydrate diet, SM/J mice and A/J mice were resistant to IGT and fatty liver compared with SMXA-5 mice \[[@CR1]\]. On the HFD, although the traits were deteriorated in all strains, both parental strains were without either diabetes or fatty liver. But SMXA-5 mice developed type 2 diabetes and fatty liver on the HFD. It was speculated that the parental strains possess the latent susceptibility loci for type 2 diabetes and fatty liver \[[@CR1]\]. We previously performed a search of genetic factors for fatty liver in SMXA-5 mice by quantitative trait locus (QTL) analysis in (SM/J × SMXA-5)F2 intercross mice \[[@CR4]\]. We detected several QTLs for liver weight, liver total lipids, liver total cholesterol (TC), and liver triglycerides (TG) on mouse chromosomes 2, 6, 10, 11, 12, and 17. On chromosome 12, a significant QTL for liver TG and highly significant QTLs for relative liver weight/liver lipid content were detected near D12Mit58 (17.1 Mb) and D12Mit270 (32.3 Mb), respectively. Chromosome 12 of SMXA-5 had the A/J-derived genome from the centromere to 54.1 Mb, and the SM/J-derived genome from 54.1 Mb to the telomere. The major QTL for fatty liver on chromosome 12 was designated *Fl1sa* (*[f]{.ul}atty[l]{.ul}iver[1]{.ul}in the[S]{.ul}MX[A]{.ul}RI strains*). The A/J allele of *Fl1sa* (on centromere-54.1 Mb) contributed to an increase in lipid accumulation in the liver. The effect of *Fl1sa* was confirmed in A/J-12^SM^ chromosomal substitution (consomic) mice \[[@CR4]\]. On the HFD, A/J-12^SM^ consomic mice that possessed the SM/J allele of *Fl1sa* showed lower lipid accumulation in the liver than A/J mice.

In this study, we first attempted to determine the time period when the differences in liver TG accumulation between A/J mice and A/J-12^SM^ mice appeared. The effect of the responsible gene(s) for *Fl1sa* that existed on the A/J-derived region of chromosome 12 (centromere-54.1 Mb) in SMXA-5 emerged after 7 weeks of feeding with the HFD. Secondly, we tried to identify candidate genes involved in the *Fl1sa-*regulated control of lipid accumulation in the liver by DNA microarray analysis. We identified only three genes that had significantly different expression levels in the liver between A/J-12^SM^ and A/J mice. The function of one of these candidate genes, mammalian *Iah1*, had not been reported, although the yeast IAH1 protein is known to show esterase activity \[[@CR5], [@CR6]\]. Thirdly, to clarify the function of mouse Iah1, we investigated lipid metabolism in the cells stably overexpressing the mouse *Iah1* gene.

Results {#Sec2}
=======

Phenotypic analyses of A/J-12^SM^ consomic mice at 3, 7, or 11 weeks of feeding with the HFD (Fig. [1](#Fig1){ref-type="fig"} and Table [1](#Tab1){ref-type="table"}) {#Sec3}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fig. 1Liver TG and total lipids of A/J mice and A/J-12^SM^ consomic mice at 3, 7, or 11 weeks of feeding with the high-fat diet. **a** Liver TG and (**b**) total lipids of A/J mice and A/J-12^SM^ mice at 3, 7, or 11 weeks of feeding with the HFD. ND, 11 weeks of feeding with the ND (*n* = 8--10; \*\**P* \< 0.01 versus A/J mice under the same experimental conditions)Table 1Body weight, body mass index, food intake, and body composition of A/J and A/J-12^SM^ strains fed the high-fat diet for 7 weeksA/J (*n* = 9)A/J-12^SM^ (*n* = 10)*P*-valueInitial body weight (g)^a^21.6 ± 0.421.3 ± 0.4NSFinal body weight (g)^b^36.2 ± 1.034.4 ± 0.7NSBody mass index (g/cm^2^)0.311 ± 0.0060.301 ± 0.006NSFood intake (g/week)20.3 ± 0.320.0 ± 0.3NSWeights of tissue (g/100 g bw)Liver4.00 ± 0.063.55 ± 0.08\*\*0.0003Subcutaneous fat^c^3.30 ± 0.193.21 ± 0.15NSEpididymal fat5.21 ± 0.145.56 ± 0.24NSRetroperitoneal fat1.45 ± 0.091.39 ± 0.09NSMesenteric fat2.75 ± 0.142.47 ± 0.12NSBlood glucose (mg/dl)224.5 ± 5.5192.7 ± 7.8\*\*0.0047Serum insulin (ng/ml)1.81 ± 0.231.08 ± 0.12\*0.0109Each value is expressed as the mean ± SEM\**P* \< 0.05, \*\**P* \< 0.01, significant difference from the value of A/J by Student's *t*-test^a^Initial body weight was measured at 6 weeks of age (at 0 weeks of feeding with the HFD)^b^Final body weight was measured at 13 weeks of age (at 7 weeks of feeding with the HFD)^c^Subcutaneous fat was defined as fat pads below the root of the forefoot on one side of the body*NS* not significant

At 11 weeks of feeding with the normal diet (ND), the body weights (A/J, 29.3 ± 0.6 g; A/J-12^SM^, 27.4 ± 0.9 g), serum TG levels (A/J, 101 ± 8 mg/dl; A/J-12^SM^, 119 ± 7 mg/dl) and serum TC levels (A/J, 100 ± 3 mg/dl; A/J-12^SM^, 106 ± 7 mg/dl) were similar between A/J mice and A/J-12^SM^ mice. Liver TG and liver total lipids in A/J-12^SM^ mice were significantly lower than those in A/J mice at 11 weeks of feeding with the HFD (Fig. [1a and b](#Fig1){ref-type="fig"}). These results were consistent with our previous study \[[@CR4]\]. However, there were no significant differences in liver TG and liver total lipids between A/J mice and A/J-12^SM^ mice at 11 weeks of feeding with the ND (Fig. [1a and b](#Fig1){ref-type="fig"}). The levels of liver total lipids in mice fed the ND were markedly lower than those in mice fed the HFD. These results indicate that *Fl1sa,* the locus for liver lipids accumulation on chromosome 12, affected HFD-induced fatty liver. Therefore, we attempted to determine the time period when the differences of liver TG accumulation between A/J mice and A/J-12^SM^ mice appeared. *Fl1sa* was detected in (SM/J × SMXA-5)F2 intercross mice at 7 weeks of feeding with the HFD \[[@CR4]\]. In this study, we analyzed the traits in A/J-12^SM^ mice and A/J mice at 3 or 7 weeks of feeding with the HFD. Feeding with the HFD increased the content of liver TG and liver total lipids compared to feeding with the ND (Fig. [1a and b](#Fig1){ref-type="fig"}), but there were no differences between A/J mice and A/J-12^SM^ mice at 3 weeks of feeding with the HFD. The levels of liver TG and liver total lipids in A/J mice increased from 3 to 7 weeks of feeding, but not in A/J-12^SM^ mice. At 7 weeks of feeding, A/J-12^SM^ mice had significantly lower contents of liver TG and of liver total lipids than A/J mice. At 7 weeks of feeding with the HFD, the body weight, body mass index, total food intake, and the weights of each type of adipose tissues (subcutaneous fat, epididymal fat, retroperitoneal fat, and mesenteric fat) did not differ between A/J mice and A/J-12^SM^ mice (Table [1](#Tab1){ref-type="table"}). The liver weight in A/J-12^SM^ mice was significantly lower than that in A/J mice. In addition, the blood glucose and serum insulin concentrations in A/J-12^SM^ mice were lower than those in A/J mice (Table [1](#Tab1){ref-type="table"}). Serum TG, serum HDL-C, and serum free fatty acids (FFA) concentrations in A/J-12^SM^ mice were similar to those in A/J mice (Fig. [2a and b](#Fig2){ref-type="fig"}). However, the serum TC level in A/J-12^SM^ mice was lower than that in A/J mice (Fig. [2a](#Fig2){ref-type="fig"}).Fig. 2Serum lipids of A/J mice and A/J-12^SM^ consomic mice at 7 weeks of feeding with the high-fat diet. **a** Serum TG, TC, HDL-C, and (**b**) serum FFA levels of A/J and A/J-12^SM^ mice at 7 weeks of feeding with the HFD (*n* = 8--10; \**P* \< 0.05 versus A/J mice)

Hepatic gene expression analyses between A/J and A/J-12^SM^ consomic mice (Table [2](#Tab2){ref-type="table"} and Fig. [3a](#Fig3){ref-type="fig"}) {#Sec4}
---------------------------------------------------------------------------------------------------------------------------------------------------

Table 2Genes differentially expressed between the livers of A/J mice and A/J-12^SM^ mice on chromosome 12Probe IDGene symbolDescriptionPosition (bp)GenBankRefSeq*P*-valueFold change**1454898_s\_atIah1isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae)21316392--21323605AU016407NM_0263470.000204.803**1459274_atGpr135G protein-coupled receptor 13572069618**--**72070991AV221890NM_1817520.000292.016**1429119_atIah1isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae)21316392--21323605AK005287NM_0263470.000592.899**1416951_a\_atAtp6v1dATPase, H+ transporting, V1 subunit D78842989**--**78861638NM_023721NM_0237210.001570.4921443933_atTc2ntandem C2 domains, nuclear101645443**--**101718523BB548141NM_0289240.001630.371**1437608_x\_atYwhaqtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide21390071--21417637BB414446NM_0117390.001833.096**1430536_a\_atErhenhancer of rudimentary homolog (Drosophila)80634022**--**80644341BB071632NM_0079510.002180.8271439045_x\_atTc2ntandem C2 domains, nuclear101645443**--**101718523AV376747NM_0289240.002450.0381421139_a\_atZfp386zinc finger protein 386 (Kruppel-like)116047724**--**116063360NM_019565NM_001004066 ; NM_0195650.002670.292**1434437_x\_atRrm2ribonucleotide reductase M224708241--24714146AV301324NM_0091040.003400.546**1446643_at5330409N07RikRIKEN cDNA 5330409 N07 gene98444816**--**98448333BB022219AK0304160.004221.9361418587_atTraf3Tnf receptor-associated factor 3111166370**--**111267153U21050NM_0116320.004230.8611420491_atEif2s1eukaryotic translation initiation factor 2, subunit 1 alpha78861819**--**78887010BC016497NM_0261140.004734.1251428810_at2700097O09RikRIKEN cDNA 2700097O09 gene55045661**--**55080110AK012621NM_0283140.005731.337**1447623_s\_atPrkd1protein kinase D150341231--50649223AV297026NM_0088580.006600.413**1449110_atRhobras homolog gene family, member B8497763**--**8499985BC018275NM_0074830.006761.7461451146_atZfp386zinc finger protein 386 (Kruppel-like)116047724**--**116063360BC004747NM_001004066 ; NM_0195650.006920.266**1434700_atG2e3G2/M-phase specific E3 ubiquitin ligase51348061--51376986BM123748NM_0010150990.008090.636**1444164_atPrpf39PRP39 pre-mRNA processing factor 39 homolog (yeast)65036333**--**65063386BG068268NM_1778060.008210.3781447341_atEsyt2extended synaptotagmin-like protein 2116281222**--**116373096BE456208NM_0287310.008591.1411454609_x\_atIrf2bplinterferon regulatory factor 2 binding protein-like86880703**--**86884814BB770958NM_1458360.009281.464**1420830_x\_atYwhaqtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide21390071--21417637NM_011739NM_0117390.009441.573**1421430_atRad51bRAD51 homolog B79297351**--**79508656NM_009014NM_0090140.009822.5961436438_s\_atDcaf5DDB1 and CUL4 associated factor 580335847**--**80436601BM234499NM_1772670.009841.410Bold genes exist in the chromosomal region of *Fl1sa*. The fold change was calculated by the gene expression level in A/J-12^SM^ relative to that in A/J miceFig. 3Gene expression levels and protein levels of candidate genes for *Fl1sa*. **a** The hepatic mRNA levels of genes identified from a DNA microarray by real-time RT-PCR analyses (*n* = 9--10; \**P* \< 0.05, \*\**P* \< 0.01 versus A/J mice). **b** The tissue distribution of *Iah1* mRNA levels in A/J and A/J-12^SM^ mice at 7 weeks of feeding with the HFD (*n* = 4--5; \**P* \< 0.05 versus A/J mice). **c** The hepatic levels of Iah1 protein in A/J and A/J-12^SM^ mice at 7 weeks of feeding with the HFD by Western blotting (*n* = 4; \*\**P* \< 0.01 versus A/J mice)

Total RNA was extracted from the livers of A/J mice or A/J-12^SM^ consomic mice fed the HFD for 7 weeks. We performed DNA microarray analysis using total RNA from the liver and compared the levels of gene expression between A/J and A/J-12^SM^. On chromosome 12, we detected 20 genes differentially expressed between A/J mice and A/J-12^SM^ mice (*P* \< 0.01) (Table [2](#Tab2){ref-type="table"}). Five genes (*Iah1*, *Ywhaq*, *Rrm2*, *Prkd1*, and *G2e3*) exist in the chromosomal region of *Fl1sa* (centromere-54.1 Mb). Using a real-time RT-PCR (qPCR) method, we confirmed that the gene expression levels of *Iah1* (isoamyl acetate-hydrolyzing esterase 1 homolog (*S. cerevisiae*), 21.3 Mb), *Rrm2* (ribonucleotide reductase M2 subunit, 24.7 Mb*)*, and *Prkd1* (protein kinase D1, 50.3 Mb) were significantly different between A/J mice and A/J-12^SM^ mice (Fig. [3a](#Fig3){ref-type="fig"}). However, the *Ywhaq* and *G2e3* mRNA levels in A/J-12^SM^ mice did not differ from those in A/J mice. The hepatic *Iah1* mRNA level in A/J-12^SM^ mice was 3.2-fold higher than that in A/J mice. In contrast, the hepatic *Rrm2* mRNA level in A/J-12^SM^ mice (0.30 ± 0.03) was significantly lower than that in A/J mice (1.00 ± 0.10). The *Prkd1* mRNA level in A/J-12^SM^ mice (0.64 ± 0.05) was also significantly lower than that in A/J mice (1.00 ± 0.08).

Tissue distributions of mouse Iah1 expression (Fig. [3b, c](#Fig3){ref-type="fig"}) {#Sec5}
-----------------------------------------------------------------------------------

Among the three genes that were confirmed to show a change of hepatic mRNA levels, we focused on the *Iah1* gene as a candidate gene for *Fl1sa*. We chose this gene because the *Iah1* mRNA level in the DNA microarray showed the lowest *P*-value and the Iah1 protein was expected to have the esterase activity (Table [2](#Tab2){ref-type="table"}).

We compared the *Iah1* mRNA level among tissues (liver, kidney, epididymal fat, lung, spleen, and muscle) by using the qPCR method (Fig. [3b](#Fig3){ref-type="fig"}). The *Iah1* mRNA levels in the liver, kidney, and lung were significantly higher in A/J-12^SM^ mice than in A/J mice. In contrast, the *Iah1* mRNA levels in epididymal fat, spleen, and muscle were similar between A/J mice and A/J-12^SM^ mice. In both A/J mice and A/J-12^SM^ mice, the *Iah1* mRNA level in the kidney was the highest among the tissues. The hepatic Iah1 protein level in A/J-12^SM^ mice was about 4.8-fold higher than that in A/J mice (Fig. [3c](#Fig3){ref-type="fig"}).

Lipid metabolism in Hepa1-6 cells stably overexpressing mouse Iah1 (Fig. [4](#Fig4){ref-type="fig"}) {#Sec6}
----------------------------------------------------------------------------------------------------

Fig. 4Overexpression of mouse Iah1 in Hepa1-6 cells. **a** The Iah1 mRNA level in non-transfected (control) and mouse *Iah1* cDNA-transfected (Iah1) cells. Iah1 cells were shown to stably overexpress mouse Iah1 protein. **b** The Iah1 protein level in control cells and mouse Iah1 cells. **c** The mRNA levels of genes related to lipid metabolism (*n* = 4--5; \**P* \< 0.05, \*\**P* \< 0.01 versus A/J mice). **d** The cellular TG contents in non-transfected (control) and mouse *Iah1* cDNA-transfected (Iah1) cells. The treatment medium consisted of serum-free medium plus 0.333 mM oleic acid and was administered to the treatment group for 48 h. The basal group was cultured in serum-free medium without oleic acid. The analyses were performed in duplicate, and at least two independent experiments were performed. The data were analyzed by two-way ANOVA. Oleic acid effect, *P* \< 0.05; Iah1 effect, not significant; Oleic acid × Iah1 (interaction) effect, not significant

We transfected mouse *Iah1* cDNA derived from SM/J into Hepa1-6 cells and obtained Hepa1-6 cells stably overexpressing the mouse Iah1 protein (Iah1-cells). The mRNA level and protein level of Iah1 in the non-transfected cells (control cells) could be detected by the qPCR method and western blotting (Fig. [4a and b](#Fig4){ref-type="fig"}). The protein level of Iah1 in the Iah1-overexpressed cells was about 42-fold higher than that in the control cells (Fig. [4b](#Fig4){ref-type="fig"}). To investigate the effect of stably overexpressing mouse Iah1 protein on lipid metabolism in hepatocytes, we performed an analysis of the mRNA levels of lipid metabolism-related genes (Fig. [4c](#Fig4){ref-type="fig"}). The mRNA levels of *Cd36* (fatty acid transporter) in the Iah1-cells were significantly lower than those in the control cells. The mRNA levels of *Mtp1* (microsomal transfer protein 1) did not differ between the control and the Iah1-cells. The genes *Pparg2* (peroxisome proliferator-activated receptor γ), *Srebf1* (sterol regulatory element binding protein 1), *Gpam* (glycerol-3-phosphate acyltransferase, mitochondrial; *Gpat*, synonymous gene symbol), and *Dgat2* (acyl-CoA:diacylglycerol acyltransferase 2) regulate fatty acid and TG synthesis. The mRNA levels of *Srebf1* and *Gpam* were higher in the Iah1-overexpressed cells compared to the control cells. In contrast, the mRNA level of *Dgat2* was significantly lower in the Iah1-overexpressed cells than in the control cells. The mRNA level of *Atgl* (adipose triglyceride lipase), which codes the protein of hepatic major TG lipase, was not changed. In the absence of oleic acid treatment (basal condition), the cellular TG contents did not differ between the control cells and Iah1-cells (Fig. [4d](#Fig4){ref-type="fig"}). After treatment with oleic acid, the cellular TG contents in both cell lines were increased. However, overexpression of Iah1did not change the cellular TG contents.

Discussion {#Sec7}
==========

We previously mapped a highly significant QTL for fatty liver (*Fl1sa*) to mouse chromosome 12 in the SMXA-5 mouse, a mouse model for HFD-induced fatty liver and type 2 diabetes. To confirm the effect of this QTL, we constructed A/J-12^SM^ consomic mice. Analysis of the A/J-12^SM^ consomic mice revealed that the SM/J allele on chromosome 12 was resistant to fatty liver \[[@CR4]\]. In this study, to elucidate the genetic basis of *Fl1sa,* we first investigated fatty liver-related traits in A/J-12^SM^ consomic mice (Table [1](#Tab1){ref-type="table"}, Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}). The phenotypic analysis of A/J-12^SM^ mice showed that the SM/J segment of chromosome 12 contributed to the lower values in liver weight, liver lipids content, blood glucose concentration, and serum insulin concentration. We previously mapped the QTLs for glucose tolerance, non-fasting blood glucose level, and serum insulin levels to the proximal region of chromosome 12 \[[@CR7]\]. On these QTLs of chromosome 12, the A/J allele increased the values of each phenotype. Therefore, the results for A/J-12^SM^ consomic mice confirmed that chromosome 12 contained not only genes involved in the regulation of liver lipid metabolism, but also several genes regulating glucose metabolism and insulin sensitivity. Significant differences in the liver lipid contents between A/J mice and A/J-12^SM^ consomic mice appeared in the animals fed an HFD for 11 weeks, but not in those on the ND (Fig. [1](#Fig1){ref-type="fig"}). These results showed that the A/J-12^SM^ consomic mice were resistant to HFD-induced fatty liver, and demonstrated that mouse chromosome 12 contained some of the genes responsible for HFD-induced fatty liver. Next, in order to identify these genes, we compared the hepatic gene expression profile between A/J mice and A/J-12^SM^ consomic mice fed the HFD, by using a DNA microarray analysis. We identified three candidate genes (*Iah1*, *Rrm2*, *Prkd1*) which had significantly different levels of expression between A/J mice and A/J-12^SM^ consomic mice within the chromosomal region of *Fl1sa* (centromere-54.1 Mb). RRM2 is one of the subunits of the ribonucleotide reductase holoenzyme. The ribonucleotide reductase, which is a rate-limiting enzyme in the production of 2'-deoxyribonucleoside 5'-triophosphates (dNTPs), is required for DNA synthesis. In a human study, expression of the *Rrm2* gene was shown to be increased in various types of cancer \[[@CR8]\]. Protein kinase D1 (PKD1), which is coded by the *Prkd1* gene, belongs to the family of stress-activated serine/threonine kinases. PKD1 is activated by the signal via Gq-coupled receptors and protein kinase C, and then phosphorylates various proteins involved in cell growth, apoptosis, adhesion, and angiogenesis \[[@CR9]\]. Dysregulation of PKD1 leads to the development of cancer and cardiac hypertrophy \[[@CR10]--[@CR12]\]. The mRNA levels of both *Rrm2* and *Prkd1* were higher in A/J than in A/J-12^SM^ mice (Fig. [3a](#Fig3){ref-type="fig"}), but occurrence of liver cancer in A/J mice has not been reported. At present, the relationship between these genes and lipid metabolism remains uncertain.

Based on the results of the DNA microarray analysis, we focused on the *Iah1* gene (Table [2](#Tab2){ref-type="table"}). A previous study reported that mouse *Iah1* mRNA was detected in the rostral striatum, kidney, liver, and lung \[[@CR13]\]. Fukuda et al. reported that the yeast IAH1 protein has esterase activity for acetate esters such as isoamyl acetate and isobutyl acetate \[[@CR6]\]. We found that the *Iah1* gene was widely expressed in mouse tissues (liver, kidney, epididymal fat, lung, spleen, muscle) (Fig. [3b](#Fig3){ref-type="fig"}), and the mRNA levels in the liver and kidney in A/J mice were especially low compared to those in A/J-12^SM^ mice. However, there has been no report about the function of the mouse Iah1 protein. We focused on the *Iah1* mRNA level, because the hepatic *Iah1* mRNA level was markedly low in A/J mice (Fig. [3](#Fig3){ref-type="fig"}). In this study, we constructed Hepa1-6 cells stably overexpressing the mouse Iah1 protein and found that overexpression of the Iah1 protein suppressed the expression levels of lipid metabolism-related genes such as *Cd36* and *Dgat2* (Fig. [4](#Fig4){ref-type="fig"}). Hepatic *Cd36* mRNA expression in C57BL/6 N mice was up-regulated by feeding with the HFD (82 % of calories as fat) for 2 weeks \[[@CR14]\]. Diet-induced obesity caused an elevation of hepatic *Cd36* expression, and this elevation was correlated with the increase in liver TG storage. *In vivo*, adenoviral gene delivery of *Cd36* to the mouse liver has been shown to lead to an increase in hepatic fatty acid uptake and TG storage in the liver \[[@CR15]\]. From our DNA microarray data, the hepatic *Cd36* mRNA level in A/J mice was about 2.6-fold higher than that in A/J-12^SM^ mice. In contrast, the mRNA levels of the other genes (*Srebf1, Gpam,* and *Dgat2*) regulated by Iah1 overexpression (Fig. [4c](#Fig4){ref-type="fig"}) were not different between these two strains (\<0.667-fold or \>1.5-fold). Our data implied that the elevation of the *Cd36* mRNA level in liver was correlated with the increase of hepatic TG accumulation. TG is synthesized via the acylation of diacylglycerol by DGAT enzymes (Dgat1 and Dgat2). Overexpression of the Dgat2 protein in mice has been reported to increase hepatic TG synthesis \[[@CR16]\]. *Dgat2*-knockout mice die soon after birth because of the significant reduction in basal TG synthesis \[[@CR17]\]. *Dgat2* antisense oligo (ASO) treatment of HFD-induced obese C57BL/6 J mice and *ob/ob* mice suppresses *Dgat2* mRNAs in the liver, resulting in a reduction in hepatic TG \[[@CR18]\]. In addition, *Dgat2* ASO treatment in rats with diet-induced hepatic steatosis was shown to reduce hepatic diacylglycerol and TG contents, but *Dgat1* ASO treatment did not reduce either \[[@CR19]\]. These reports indicate that the reduction of the mRNA levels of *Cd36* and *Dgat2* in liver contributes to the suppression of lipid accumulation in the liver.

We speculate that the elevation of *Iah1* gene expression suppresses the TG synthesis and the liver lipid accumulation via the reduction of *Cd36* and *Dgat2* expression. However, the regulatory mechanisms of *Cd36* and *Ggat2* gene expressions by *Iah1* are unknown. In *S. cerevisiae*, the IAH1 protein exhibits esterase activity against the ester bonds between alcohol and fatty acid \[[@CR5], [@CR6]\]. Therefore, we also speculate that the substrates and/or the metabolites that were catalyzed by the mouse Iah1 protein might regulate the expressions of genes related to lipid metabolism. Although the esterase properties of the mouse Iah1 protein are not yet known, we are currently trying to clarify the physiological substrates of this protein.

Conclusions {#Sec8}
===========

This study demonstrated that *Fl1sa*, a QTL for fatty liver on the proximal region of chromosome 12, was the locus that was affected by feeding with the HFD, but not affected by the ND. We also showed that mouse *Iah1* is a candidate gene for *Fl1sa.* Finally, we showed for the first time that *Iah1* regulated the expressions of the *Cd36* and *Dgat2* genes, which play important roles in TG synthesis and lipid metabolism. In future experiments, to identify the gene responsible for *Fl1sa*, we will construct several congenic strains. By using these congenic mice, we can finely map the chromosomal region containing the responsible gene. Simultaneously, to determine whether the *Iah1* gene is responsible for *Fl1sa*, we will construct *Iah1*-knockout mice, which will contribute to the functional analysis of mouse Iah1. Based on our present findings, Iah1 might prove to be a novel mediator of lipid metabolism.

Methods {#Sec9}
=======

Animals {#Sec10}
-------

The A/J-Chr12^SM^ consomic strain was produced at the Institute for Laboratory Animal Research, Nagoya University School of Medicine. The A/J-12^SM^ consomic mouse strain was established by introduction of the donor SM/J chromosome 12 into the recipient A/J background as previously described \[[@CR20]\]. A/J male mice were purchased from Japan SLC (Hamamatsu, Japan). In this study, only male mice were used for the phenotypic analyses. Mice were maintained in a temperature-controlled room (23 ± 2 °C) and 55 ± 5 % humidity with a 12-h light/dark cycle and ad libitum access to food and water under conventional conditions. Mice were weaned at 3 weeks of age in a cage containing five animals or fewer. Until 6 weeks of age, all mice were fed a rodent standard laboratory chow (CE2; Nihon CLEA, Japan). Animal care and all experimental procedures were approved by the Animal Experiment Committee, Graduate School of Bioagricultural Sciences, Nagoya University (approval No. 2008031801, 2011030404, 2012022805), and were conducted according to the Regulations on Animal Experiments of Nagoya University.

Experimental schedule and diet composition {#Sec11}
------------------------------------------

From 6 weeks of age, mice were switched from their standard laboratory diets to the HFD (HFD group), or continued to be fed their standard laboratory diets (ND group). In the ND group, A/J mice and A/J-12^SM^ mice were kept at one animal per cage and fed the standard laboratory chow for 11 weeks. After 11 weeks of feeding with the ND, the mice were killed by decapitation, and the liver was collected at 13:00--14:00 h after 4-h diet deprivation. In the HFD group, A/J mice and A/J-12^SM^ consomic mice were kept at one animal per cage and fed the powdered HFD for 3, 7, or 11 weeks. The composition of the powdered HFD (weight %) was as follows: casein, 20.9; carbohydrate (corn starch: sucrose, 1:1), 36.9; AIN93MX mineral mixture, 3.5; AIN93VX vitamin mixture, 1.0; choline chloride, 0.2; corn oil, 3.5; lard, 30.0; and cellulose (AVICEL type FD-101; Asahi Chemical Industry, Osaka, Japan), 4.0. The content of fat in this HFD was 33.5 % (weight %). After 3, 7, or 11 weeks on the HFD, mice were killed by decapitation, and the serum, liver, and fat pads were collected at 13:00--14:00 h after 4-h diet deprivation. After 7 weeks on the HFD, the measurement of BMI was performed as in our previous report \[[@CR21]\]. BMI was calculated as body weight (g) divided by the square of the anal-nasal length (cm).

Hepatic lipid analysis {#Sec12}
----------------------

Frozen livers were homogenized with chloroform:methanol (2:1), and the liver lipids were extracted into organic solvents. A portion of this extract was dried, and the hepatic contents of TG and TC were measured by the triglyceride E-test (Wako, Tokyo, Japan) and the cholesterol E-test (Wako), respectively. This extract was also used to measure total liver lipids according to the method of Folch et al. \[[@CR22]\].

Serum glucose, insulin, and lipids {#Sec13}
----------------------------------

The serum glucose concentration was measured by a glucose oxidase method (Glucose-B test Kit; WAKO, Tokyo, Japan). Serum insulin, TG, TC, HDL-C, and non-esterified free fatty acid concentrations were measured at the end of the experiment (after 7 weeks of feeding with the HFD) by using a Mouse Insulin ELISA kit (Morinaga Institute of Biological Sciences Inc., Japan), Triglyceride-E kit (WAKO Pure Chemical Industries, Japan), Cholesterol-E kit (WAKO Pure Chemical Industries), HDL-Cholesterol-E kit (WAKO Pure Chemical Industries), and NEFA C-kit (WAKO Pure Chemical Industries), respectively.

Microarray experiments {#Sec14}
----------------------

Liver samples were collected from A/J male mice and A/J-12^SM^ male mice fed the HFD for 7 weeks. Total RNA was isolated from the liver using TRI reagent (Molecular Research Center Inc.) and cleaned using an RNeasy Mini kit (Qiagen). We extracted the total RNA from nine mice per strain. Extracted total RNA quality was assessed with an Agilent Bioanalyzer (Agilent Technologies). cDNA synthesis and cRNA labeling reactions were performed with a One-Cycle cDNA Synthesis Kit and IVT Labeling Kit (Affymetrix). In order to minimize the experimental variation, we used three arrays for each strain and obtained data from three replicates. Each biotinylated cRNA was prepared from the pooled RNA samples of three mice. The biotinylated cRNAs were hybridized with a probe array (Mouse Genome 430 2.0 Array) by using a Hybridization, Wash and Stain kit (Affymetrix). Scanning was performed using a Scanner 3000 with GeneChip Operating Software (GCOS) (Affymetrix). Raw data were normalized with the MAS5.0 algorithm by using Expression Console Software (Affymetrix). The microarray data have been deposited in the NCBI Gene Expression Omnibus (GEO) (GSE67340). Data were analyzed by using GeneSpring GX7.3 software (Agilent Technologies).

Real-time RT-PCR {#Sec15}
----------------

Total RNA was extracted from liver and Hepa1-6 cells using TRI reagent. To eliminate DNA contamination, the RNA was treated with DNase (TURBO DNA-free; Life Technologies). Subsequently, the cDNA was synthesized by using a High Capacity Reverse Transcription kit (Life Technologies). Gene expression was quantified by real-time PCR using an ABI 7300 real-time PCR System with Thunderbird qPCR Mix or Thunderbird SYBR qPCR Mix (Toyobo, Tokyo, Japan). TaqMan primers and probes were used to determine the mRNA levels of mouse Iah1 (TaqMan Gene Expression Assays, Mm00509467_m1; Applied Biosystems) and 18S rRNA (Pre-developed TaqMan Assay Reagents, Eukaryotic 18S rRNA 4319413E; Applied Biosystems). The primers used for the SYBR Green assay are shown in Additional file [1](#MOESM1){ref-type="media"}. The level of each mRNA was normalized to that of the corresponding 18S rRNA.

Western blotting {#Sec16}
----------------

The tissues and cells were homogenized in lysis buffer (10 mM Tris (pH 7.4), 150 mM NaCl, 1 % Nonidet P-40, 0.5 % sodium deoxycholate, 0.1 % SDS) containing protease inhibitor cocktail (Complete Mini, Roche Applied Science) with a homogenizer (HG-30; Hitachi). The homogenates were centrifuged at 10,000 × g for 5 min and the supernatant was obtained as protein extracts. An aliquot of protein (4 μg) was subjected to SDS-PAGE on 10 % acrylamide gel, and the proteins in the gel were transferred onto PVDF membranes (Hybond P; GE Healthcare). The membranes were incubated for 30 min at room temperature with Blocking One (Nacalai Tesque) and incubated overnight at 4 °C with the first antibody, rabbit polyclonal anti-mouse Iah1 (1:20,000) and anti-β-actin (1:10,000; \#4967; Cell Signaling Technology Inc.), then washed with TBS buffer containing 0.1 % Tween 20. The membranes were incubated with the horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (1:20,000 or 1:10,000; \#7074; Santa Cruz Biotechnology, USA) for 1 h at room temperature and washed. Each antibody was diluted with Can Get Signal (Toyobo). The membranes were autographed with a West Dura Western Blot Detection kit using the ECL method (Thermo Fisher Scientific). Each protein on the band was quantified with Image J software.

Hepa1-6 cell culture and overexpression of mouse Iah1 {#Sec17}
-----------------------------------------------------

Hepa1-6 cells, a mouse hepatocyte cell line (RBRC-RCB1638 RIKEN BRC Cell Bank), were grown in high-glucose Dulbecco's modified Eagle's medium (DMEM; Wako Pure Chemical) supplemented with 10 % fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin at 37 °C in a 5 % CO~2~-humidified incubator.

Iah1 cDNA of SM/J mice was amplified with the KOD-plus (TOYOBO) using the following primers: an upper primer containing the start codon, CTTTCTACCATGTCGCTGTGC; a lower primer containing the stop codon, CTAATAGTCTCCATCTCCCAGCAG. The cDNA fragment was subcloned into pcDNA3.3 TOPO plasmid (Thermo Fisher Scientific). The Iah1-expressing plasmid vector with CMV promoter contained Iah1 cDNA (759 bp) constructed from SM/J mice. To construct the mouse Iah1-expressing stable cell line, Hepa1-6 cells were seeded on 12-well plates (3 × 10^5^ cells per well) on day 0. After 24 h, the *Iah1*-expressing plasmid vector (1.4 μg) was transfected using Lipofectamine 2000 reagent (Invitrogen). After 28 h of transfection, the transfected cells were subcultured on a 60 mm dish (6000 cells per dish) and incubated for 1 week. For the selection of neomycin-resistant cells, cells were maintained in medium containing 500 μg/ml G418 disulfate salt (Sigma Aldrich). Three weeks after colony selection with G418, we obtained the Iah1 cDNA-expressing stable cell line.

To assay the effect of overexpression of Iah1 on various mRNA levels, cells were plated on 12-well plates (2 × 10^5^ cells per well) on day 0. After 72 h, the cells were harvested and used for the assay of protein or the extraction of total RNA.

To examine the effect of overexpression of Iah1 on the intracellular accumulation of triglycerides, cells were seeded on 12-well plates (2.5 × 10^5^ cells per well) at day 0. At day 1, the culture medium was replaced with serum-free medium containing 0.333 mM oleic acid (oleic acid-BSA conjugated solution, finally containing 1 % BSA, (Sigma)) or serum-free medium alone. The treatment medium without oleic acid-BSA was supplemented with 1 % BSA. After 2 days, the cells were homogenized in lysis buffer (50 mM Tris--HCl pH 7.4, 150 mM NaCl, 2 mM EDTA, 1 % Triton X-100, and 0.5 % cholate). The supernatants were obtained by centrifugation at 9730 × g for 10 min at 4 °C. Their triglycerides and protein concentration were measured by a Triglyceride-E test and a DC protein assay (Bio-Rad Laboratories, Japan), respectively. The triglycerides content in cells was normalized to that of protein content.

Statistical analysis {#Sec18}
--------------------

The results are expressed as the means with their standard errors. Mean values, except for the data in Fig. [4d](#Fig4){ref-type="fig"}, were compared using Student's *t-*test when the variances of each group were equal. When the variances of each group were unequal, the significance of differences was determined using Welch's test. The data from Fig. [4d](#Fig4){ref-type="fig"} were analyzed by two-way ANOVA. Differences with *P* \< 0.05 were regarded as significant. General statistical analyses were also performed using StatView version 5.0 software (SAS Institute).
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